Cathie Wood Stock Portfolio: 5 Newest Stock Picks This Year

In this piece, we will take a look at the five newest additions to Cathie Wood’s latest stock portfolio. If you want to learn more about the hedge fund and its owner, head on to Cathie Wood Stock Portfolio: 7 Newest Stock Picks This Year.

5. COMPASS Pathways plc (NASDAQ:CMPS)

Ark Investment’s Stake Value: $4.1 million

Percentage of Ark Investment’s 13F Portfolio: 0.02%

Number of Hedge Fund Holders: 12

COMPASS Pathways plc (NASDAQ:CMPS) is a British healthcare company that is headquartered in London, the United Kingdom. The firm develops treatments for mental illnesses, and its COMP360 treatment has completed trials for the treatment of resilient depression and is currently undergoing trials for the treatment of complex post traumatic stress disorder.

Ark Investment bought 388,574 COMPASS Pathways plc (NASDAQ:CMPS) shares during this year’s third quarter, which allowed it to own a $4.1 million stake in the company. Insider Monkey’s Q2 2022 survey of 895 hedge funds revealed that 12 have also bought the company’s shares. Oppenheimer reduced its price target for COMPASS Pathways plc (NASDAQ:CMPS) to $55 from $65 in October 2022, as it stated that uncertainty surrounding filing requirements influenced the decision. However, the firm still has an Outperform rating for the shares.

COMPASS Pathways plc (NASDAQ:CMPS) is also financing seven other treatments for several diseases such as bipolar disorder, autism, and suicide ideation at different universities. Some of these universities include Columbia University, King’s College in London, and the University of Copenhagen.

COMPASS Pathways plc (NASDAQ:CMPS)’s largest investor in our database as of the second quarter is Christopher Medlock James’s Partner Fund Management which owns 392,764 shares that are worth $4.2 million.